MeVis Medical Solutions AG (FRA:M3V) Total Assets: €23.16 Mil (As of Mar. 2026)


FRA:M3V MeVis Medical Solutions AG FRA:M3V
66 GF Score
Price €24.00
GF Value €22.72
! 5 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG Total Assets?

MeVis Medical Solutions AG FRA:M3V 66 Total Assets is €23.16 Mil as of Mar. 2026. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.72. The stock has 5 warning signs investors should review.

MeVis Medical Solutions AG's Total Assets for the quarter that ended in Mar. 2026 was €23.16 Mil.

During the past 12 months, MeVis Medical Solutions AG's average Total Assets Growth Rate was -7.20% per year. During the past 3 years, the average Total Assets Growth Rate was -4.00% per year. During the past 5 years, the average Total Assets Growth Rate was -3.10% per year. During the past 10 years, the average Total Assets Growth Rate was -0.10% per year.

During the past 13 years, MeVis Medical Solutions AG's highest 3-Year average Total Assets Growth Rate was 118.90%. The lowest was -17.60%. And the median was -1.50%.

Total Assets is connected with ROA %. MeVis Medical Solutions AG's annualized ROA % for the quarter that ended in Mar. 2026 was 5.07%. Total Assets is also linked to Revenue through Asset Turnover. MeVis Medical Solutions AG's Asset Turnover for the quarter that ended in Mar. 2026 was 0.32.


MeVis Medical Solutions AG  (FRA:M3V) Total Assets Explanation

Total Assets is connected with ROA %.

MeVis Medical Solutions AG's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=1.244/( (25.886+23.162)/ 2 )
=1.244/24.524
=5.07 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

MeVis Medical Solutions AG's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=7.861/( (25.886+23.162)/ 2 )
=7.861/24.524
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

MeVis Medical Solutions AG Total Assets Related Terms


MeVis Medical Solutions AG Total Assets Historical Data

* Premium members only.

The historical data trend for MeVis Medical Solutions AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeVis Medical Solutions AG Total Assets Chart

MeVis Medical Solutions AG Annual Data
Trend Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.53 31.20 28.05 26.48 25.89

MeVis Medical Solutions AG Semi-Annual Data
Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.13 26.48 23.60 25.89 23.16
FRA:M3V
66GF Score
MeVis Medical Solutions AG FRA:M3V
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeVis Medical Solutions AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

MeVis Medical Solutions AG's Total Assets for the fiscal year that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (A: Sep. 2025 )+Total Liabilities (A: Sep. 2025 )
=17.826+8.06
=25.89

MeVis Medical Solutions AG's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=17.826+5.336
=23.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €23.16 Mil mean?
MeVis Medical Solutions AG (FRA:M3V) has a Total Assets of €23.16 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on MeVis Medical Solutions AG and its competitors.
Is MeVis Medical Solutions AG's Total Assets too high?
MeVis Medical Solutions AG's current Total Assets is €23.16 Mil. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Total Assets compare to VEEV and BTSG?
MeVis Medical Solutions AG's Total Assets of €23.16 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Healthcare Providers & Services company?
A good Total Assets depends on the Healthcare Providers & Services industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on MeVis Medical Solutions AG and its competitors. MeVis Medical Solutions AG's current Total Assets is €23.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Total Assets of €23.16 Mil. The stock's GF Value™ is €22.72, compared to a current price of €24.00 — trading 5.6% above its estimated fair value. The current Total Assets is €23.16 Mil. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Total Assets is €23.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €24.00 is trading 5.6% above its estimated GF Value™ of €22.72.

Key valuation signals for FRA:M3V:

  • Total Assets: €23.16 Mil
  • GF Value™: €22.72 vs. price of €24.00 (5.6% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges 0HI7:UKM3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score

Get the complete analysis for FRA:M3V

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.00
Price
€22.72
GF Value